MoneyWorks4Me

Neuland Laboratories receives EIR from USFDA for Bonthapally facility

30 Aug 2019 Evaluate

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Bonthapally, Hyderabad. The facility was inspected from June 17, 2019 to June 21, 2019.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..